Importantly, the patient fulfilled criteria for probable bvFTD, however, CSF biomarkers signature showing low Aβ42, high Tau, and high p-Tau established a diagnosis of the frontal variant of AD (40). The gene discussed is MAPT; the disease is behavioral variant of frontotemporal dementia.